Vertex Pharmaceuticals

VRTX

505.40
USD
9.75
(1.97%)
Market Open
Volume
10,873
EPS
0
Div Yield
0
P/E
-240
Market Cap
122,407,550,795
Related Instruments
AMGN
2.78
(0.84%)
335.22 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
B
BMRN
0.270
(0.32%)
84.620 USD
GILD
0.470
(0.62%)
76.510 USD
I
ILMN
-0.250
(-0.20%)
122.370 USD
I
INCY
-0.680
(-1.05%)
64.390 USD
REGN
13.14
(1.22%)
1,091.19 USD
R
RGEN
-1.970
(-1.18%)
165.630 USD
News

Title: Vertex Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Vertex Pharmaceuticals is an American biopharmaceutical company in the business of researching, developing, manufacturing and marketing small molecule drugs for human patients with serious diseases. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, Massachusetts. Some of the diseases impacted by its therapies include cystic fibrosis; infectious diseases, including viral infections, such as influenza and bacterial infections; rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders. The company was one of the early pioneers of rational drug design rather than combinatorial chemistry.